• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN PLEASANTON COOLSCULPTING ELITE SYSTEM; DERMAL COOLING PACK/VACUUM/MASSAGER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN PLEASANTON COOLSCULPTING ELITE SYSTEM; DERMAL COOLING PACK/VACUUM/MASSAGER Back to Search Results
Catalog Number CS-S3-002-D-00
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hyperplasia (1906)
Date of Event 10/01/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Paradoxical adipose hyperplasia (ph/pah) is a known potential adverse event addressed in the product labeling.According to the coolsculpting user manual, under rare adverse events, paradoxical adipose hyperplasia (ph/pah) is characterized by a visibly enlarged tissue volume within the treatment area, which may develop two to five months after treatment.Surgical intervention may be required.Pah is not related to any coolsculpting device failure mode but it is included in the risk management files of the device because it is a risk that is inherent to the use cryolipolysis for localized fat reduction.A supplemental report will be submitted if and when additional information is obtained.
 
Event or Problem Description
Allergan aesthetics received a report of a patient treated with coolsculpting treatment to the abdomen and flanks on (b)(6) 2023 and possibly developed paradoxical hyperplasia (pah/ph).
 
Event or Problem Description
Allergan aesthetics received a report of a patient treated with coolsculpting elite treatment on (b)(6) 2023 using the curve 150 (c150) applicator to the abdomen and flanks.The patient was diagnosed on (b)(6) 2024 with paradoxical hyperplasia (ph) to the low abdomen and mid abdomen.
 
Additional Manufacturer Narrative
Additional information: paradoxical adipose hyperplasia (ph) is a known potential adverse event addressed in the product labeling.According to the coolsculpting user manual, under rare adverse events, paradoxical adipose hyperplasia (ph) is characterized by a visibly enlarged tissue volume within the treatment area, which may develop two to five months after treatment.Surgical intervention may be required.Ph is not related to any coolsculpting device failure mode but it is included in the risk management files of the device because it is a risk that is inherent to the use cryolipolysis for localized fat reduction.A supplemental report will be submitted if and when additional information is obtained.
 
Additional Manufacturer Narrative
Correction: h11.Additional information was missing from 3007215625-2024-00547.
 
Event or Problem Description
Allergan aesthetics received a report of a patient treated with coolsculpting elite treatment on (b)(6) 2023 and (b)(6) 2023 using the curve 150 (c150) applicator to the abdomen and flanks.The patient was diagnosed on (b)(6) 2024 with paradoxical hyperplasia (ph) to the low abdomen and mid abdomen.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COOLSCULPTING ELITE SYSTEM
Common Device Name
DERMAL COOLING PACK/VACUUM/MASSAGER
Manufacturer (Section D)
ALLERGAN PLEASANTON
4410 rosewood dr
pleasanton CA 94588
Manufacturer (Section G)
DUBLIN
4410 rosewood dr
pleasanton CA 94588
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key19367357
Report Number3007215625-2024-00547
Device Sequence Number7880240
Product Code OOK
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K183514
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberCS-S3-002-D-00
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/30/2024
Supplement Date Received by Manufacturer07/02/2024
07/24/2024
Initial Report FDA Received Date05/21/2024
Supplement Report FDA Received Date07/24/2024
07/24/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexFemale
Patient Weight71 KG
Patient RaceWhite
-
-